Trials / Active Not Recruiting
Active Not RecruitingNCT05839873
Abbott Ventricular Tachycardia PAS
Abbott Ventricular Tachycardia Post Approval Study
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 62 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 7 Years
- Healthy volunteers
- Not accepted
Summary
This post-approval study (PAS) is designed to provide continued clinical evidence to confirm the long-term safety and effectiveness of the FlexAbilityTM Ablation Catheter, Sensor EnabledTM (FlexAbility SE) for the treatment of ventricular tachycardia in a post-market environment. This is a prospective, single arm, open-label, multi-center, observational study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | FlexAbility SE Ablation Catheter | Subjects receive ablation treatment. |
Timeline
- Start date
- 2023-07-24
- Primary completion
- 2026-08-01
- Completion
- 2026-11-01
- First posted
- 2023-05-03
- Last updated
- 2025-10-20
Locations
11 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05839873. Inclusion in this directory is not an endorsement.